株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の幹細胞治療市場規模:タイプ別、用途別、エンドユース別、業界分析、地域別の見通し、潜在的技術、競合市場シェアおよび予測

Stem Cell Therapy Market Size By Type, By Application, End-users Industry Analysis Report, Regional Outlook, Technology Potential, Competitive Market Share & Forecast, 2019 - 2025

発行 Global Market Insights Inc. 商品コード 882345
出版日 ページ情報 英文 130 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.41円で換算しております。
Back to Top
世界の幹細胞治療市場規模:タイプ別、用途別、エンドユース別、業界分析、地域別の見通し、潜在的技術、競合市場シェアおよび予測 Stem Cell Therapy Market Size By Type, By Application, End-users Industry Analysis Report, Regional Outlook, Technology Potential, Competitive Market Share & Forecast, 2019 - 2025
出版日: 2019年06月20日 ページ情報: 英文 130 Pages
概要

当レポートでは、世界の幹細胞治療市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

第3章 業界動向

  • 業界セグメンテーション
  • 業界環境
  • 業界影響因子
    • 成長促進因子
    • 落とし穴と課題
  • 成長可能性分析
  • ポーターズ分析
  • 競合環境
  • PESTEL分析

第4章 製品タイプ別市場

  • 主要セグメント動向
  • 同種幹細胞治療
  • 自己感細胞治療

第5章 用途別市場

  • 主要セグメント動向
  • 腫瘍
  • 整形外科
  • 心血管
  • 神経科
  • その他

第6章 エンドユーザー別市場

  • 主要セグメント動向
  • 病院
  • クリニック
  • その他

第7章 地域別市場

  • 主要セグメント動向
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 企業プロファイル

  • Astellas Pharma Inc
  • Capricor Therapeutics
  • Cellectis
  • Cellular Dynamics
  • Celyad
  • CESCA Therapeutic
  • DiscGenics
  • Gamida Cell
  • Mesoblast Ltd
  • Novadip Biosciences
  • OxStem
  • ReNeuron Group plc
  • 武田薬品工業株式会社
図表

Data Tables

  • TABLE 1. Stem cells therapy industry 36 degree synopsis, 2014 - 2025
  • TABLE 2. Stem cells therapy market size, 2014 - 2025 (USD Million)
  • TABLE 3. Stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 4. Stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 5. Stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 6. Industry impact forces
  • TABLE 7. Allogenic stem cell therapy market size, by region, 2014 - 2025 (USD Million)
  • TABLE 8. Autologous stem cell therapy market size, by region, 2014 - 2025 (USD Million)
  • TABLE 9. Oncology market size, by region, 2014 - 2025 (USD Million)
  • TABLE 10. Orthopedic market size, by region, 2014 - 2025 (USD Million)
  • TABLE 11. Cardiovascular market size, by region, 2014 - 2025 (USD Million)
  • TABLE 12. Neurology size, by region, 2014 - 2025 (USD Million)
  • TABLE 13. Hospitals market size, by region, 2014 - 2025 (USD Million)
  • TABLE 14. Clinics size, by region, 2014 - 2025 (USD Million)
  • TABLE 15. Others market size, by region, 2014 - 2025 (USD Million)
  • TABLE 16. North America stem cells therapy market size, by country, 2014 - 2025 (USD Million)
  • TABLE 17. North America stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 18. North America stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 19. North America stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 20. U.S. stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 21. U.S. stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 22. U.S. stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 23. Canada stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 24. Canada stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 25. Canada stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 26. Europe stem cells therapy market size, by country, 2014 - 2025 (USD Million)
  • TABLE 27. Europe stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 28. Europe stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 29. Europe stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 30. Germany stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 31. Germany stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 32. Germany stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 33. UK stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 34. UK stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 35. UK stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 36. France stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 37. France stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 38. France stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 39. Italy stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 40. Italy stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 41. Italy stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 42. Spain stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 43. Spain stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 44. Spain stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 45. Russia stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 46. Russia stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 47. Russia stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 48. Asia Pacific stem cells therapy market size, by country, 2014 - 2025 (USD Million)
  • TABLE 49. Asia Pacific stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 50. Asia Pacific stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 51. Asia Pacific stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 52. Japan stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 53. Japan stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 54. Japan stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 55. China stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 56. China stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 57. China stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 58. India stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 59. India stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 60. India stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 61. South Korea stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 62. South Korea stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 63. South Korea stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 64. Australia stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 65. Australia stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 66. Australia stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 67. Latin America stem cells therapy market size, by country, 2014 - 2025 (USD Million)
  • TABLE 68. Latin America stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 69. Latin America stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 70. Latin America stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 71. Brazil stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 72. Brazil stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 73. Brazil stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 74. Mexico stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 75. Mexico stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 76. Mexico stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 77. Argentina stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 78. Argentina stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 79. Argentina stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 80. MEA stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 81. MEA stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 82. MEA stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 83. Saudi Arabia stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 84. Saudi Arabia stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 85. Saudi Arabia stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 86. South Africa stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 87. South Africa stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 88. South Africa stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)
  • TABLE 89. UAE stem cells therapy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 90. UAE stem cells therapy market size, by application, 2014 - 2025 (USD Million)
  • TABLE 91. UAE stem cells therapy market size, by end-users, 2014 - 2025 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Stem cells therapy market size, 2014 - 2025 (USD Million)
  • FIG. 3 Growth potential analysis, by type
  • FIG. 4 Growth potential analysis, by application
  • FIG. 5 Growth potential analysis, by end-users
  • FIG. 6 Porter's analysis
  • FIG. 7 Strategy dashboard, 2018
  • FIG. 8 PESTEL analysis
目次
Product Code: 3331

Title:
Stem Cell Therapy Market Size By Type (Allogenic Stem Cell Therapy, Autologous Stem Cell Therapy), By Application (Oncology, Orthopedic, Cardiovascular, Neurology), End-users (Hospitals, Clinics) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, South Korea, Argentina, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Technology Potential, Competitive Market Share & Forecast, 2019 - 2025.

Stem Cell Therapy Market will exceed USD 15 billion by 2025; as per a new research report.

Increasing research on developing novel therapies and personalized medicines will foster stem cell therapy market growth. For instance, scientists are extensively researching on methods to regenerate healthy heart cells from placenta that can be used in patients after myocardial infarction. This discovery will help to cure patients suffering from cardiovascular diseases and reduce mortality rates. Researchers are further examining different aspects of stem cell therapy for its applications in neurological disorders. Thus, increasing R&D activities to promote developments in stem cell therapy will positively impact the industry growth.

Rising geriatric population will positively influence the industry growth in coming years. Elderly people are susceptible to degenerative diseases such as Parkinson's and Alzheimer's disorders. Stem cell therapies offer several benefits over the conventional therapeutic methods that raises its preference for curing degenerative diseases. Recently developed stem cell therapies generate healthy cells by replacing the defective cells through minimally invasive techniques. Therefore, geriatric population rely on stem cell therapies that proves beneficial for the industry growth.

Allogenic stem cell therapy segment was valued around USD 3 billion in 2018 and is anticipated to expand substantially in near future. Allogenic transplant completely replaces host cells with donor cells. It also has the potential to eliminate viral reservoirs and genetic alterations. Therefore, allogenic stem cell therapies have been extensively utilized in providing treatment to patients suffering from leukemia and several other life threatening diseases. Thus, benefits offered by allogenic stem cell therapy will surge its demand, thereby propelling segment growth.

Orthopedic segment is anticipated to witness more than 9% growth over the forecast time frame. Substantial growth is attributed to rising accidents and trauma cases across the globe. Stem cell therapy is successfully applicable in treating bone-joint injuries that include spinal and fractured bone defects, ligament tendon, femoral head and osteogenesis imperfecta. Mesenchymal stem cell therapy is preferred in curing orthopedic diseases such as arthritis and osteoporosis due to its ability to differentiate into bones and cartilage. Above mentioned factors will surge segment growth.

Clinics segment accounted for around 35% revenue share in 2018. Clinics are equipped with advanced medical equipment and skilled professionals that enables it to provide superior quality stem cell therapies. Clinics can deliver specialized stem cell treatment in areas such as cardiovascular, oncology or orthopedics that should prove beneficial for the segmental growth. However, as the treatments offered at clinics are expensive, that may have a short term impact on the segment growth.

Europe is anticipated to witness around 10% growth during analysis time frame. Substantial growth is attributed to increasing prevalence of chronic diseases in the region. Moreover, the regulatory scenario for stem cell therapies is also improving gradually. Initially stringent regulations lowered the demand for stem cell therapies. However, as people started becoming aware regarding advantages associated with stem cell therapy, its adoption escalated. Above-mentioned factors fosters the regional growth.

Prominent industry players operational in the stem cell therapy include Astellas Pharma, Cellectis, Celyad, ReNeuron Group, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, Novadip Biosciences, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast, and Takeda Pharmaceuticals. These key players adopt several initiatives such mergers, acquisitions and new product launches to sustain market position. Besides these strategies, companies also undertake promotional strategies that enhance their sales. For instance, in June 2018, CESCA Therapeutics announced exhibition at Orthobiologic Institute's ninth annual PRP and regenerative medicine symposium. This strategy was company's promotional effort in order to gain attention of customers.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Stem cell therapy industry 360 degree synopsis, 2014 - 2025
    • 2.1.1. Business trends
    • 2.1.2. Type trends
    • 2.1.3. Application trends
    • 2.1.4. End-users trends
    • 2.1.5. Regional trends

Chapter 3. Stem Cell Therapy Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Advancements in regenerative medicine in North America & Europe
      • 3.3.1.2. Increasing government initiatives for stem cell therapy in developed as well as developing countries
      • 3.3.1.3. Rising awareness regarding availability of stem cell therapy in developing and underdeveloped countries
      • 3.3.1.4. Growing prevalence of chronic diseases
      • 3.3.1.5. Increasing research and development activities undertaken by companies for stem cell therapy
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. High cost of stem cell therapy
      • 3.3.2.2. Ethical issues associated with stem cell therapy
  • 3.4. Growth potential analysis
    • 3.4.1. By type
    • 3.4.2. By application
    • 3.4.3. By end-users
  • 3.5. Ecosystem analysis
  • 3.6. Porter's analysis
  • 3.7. Competitive landscape, 2018
    • 3.7.1. Strategy dashboard
  • 3.8. PESTEL analysis

Chapter 4. Stem Cell Therapy Market, By Type

  • 4.1. Key segment trends
  • 4.2. Allogenic stem cell therapy
    • 4.2.1. Market size, by region, 2014-2025 (USD Million)
  • 4.3. Autologous stem cell therapy
    • 4.3.1. Market size, by region, 2014-2025 (USD Million)

Chapter 5. Stem Cell Therapy Market, By Application

  • 5.1. Key segment trends
  • 5.2. Oncology
    • 5.2.1. Market size, by region, 2014-2025 (USD Million)
  • 5.3. Orthopedic
    • 5.3.1. Market size, by region, 2014-2025 (USD Million)
  • 5.4. Cardiovascular
    • 5.4.1. Market size, by region, 2014-2025 (USD Million)
  • 5.5. Neurology
    • 5.5.1. Market size, by region, 2014-2025 (USD Million)
  • 5.6. Others
    • 5.6.1. Market size, by region, 2014-2025 (USD Million)

Chapter 6. Stem Cell Therapy Market, By End-users

  • 6.1. Key segment trends
  • 6.2. Hospitals
    • 6.2.1. Market size, by region, 2014-2025 (USD Million)
  • 6.3. Clinics
    • 6.3.1. Market size, by region, 2014-2025 (USD Million)
  • 6.4. Others
    • 6.4.1. Market size, by region, 2014-2025 (USD Million)

Chapter 7. Stem Cell Therapy Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size, by country, 2014-2025 (USD Million)
    • 7.2.2. Market size, by type, 2014-2025 (USD Million)
    • 7.2.3. Market size, by application, 2014-2025 (USD Million)
    • 7.2.4. Market size, by end-users, 2014-2025 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by type, 2014-2025 (USD Million)
      • 7.2.5.2. Market size, by application, 2014-2025 (USD Million)
      • 7.2.5.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by type, 2014-2025 (USD Million)
      • 7.2.6.2. Market size, by application, 2014-2025 (USD Million)
      • 7.2.6.3. Market size, by end-users, 2014-2025 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2014-2025 (USD Million)
    • 7.3.2. Market size, by type, 2014-2025 (USD Million)
    • 7.3.3. Market size, by application, 2014-2025 (USD Million)
    • 7.3.4. Market size, by end-users, 2014-2025 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by type, 2014-2025 (USD Million)
      • 7.3.5.2. Market size, by application, 2014-2025 (USD Million)
      • 7.3.5.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.3.6. UK
      • 7.3.6.1. Market size, by type, 2014-2025 (USD Million)
      • 7.3.6.2. Market size, by application, 2014-2025 (USD Million)
      • 7.3.6.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market size, by type, 2014-2025 (USD Million)
      • 7.3.7.2. Market size, by application, 2014-2025 (USD Million)
      • 7.3.7.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by type, 2014-2025 (USD Million)
      • 7.3.8.2. Market size, by application, 2014-2025 (USD Million)
      • 7.3.8.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.3.9. Spain
      • 7.3.9.1. Market size, by type, 2014-2025 (USD Million)
      • 7.3.9.2. Market size, by application, 2014-2025 (USD Million)
      • 7.3.9.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.3.10. Russia
      • 7.3.10.1. Market size, by type, 2014-2025 (USD Million)
      • 7.3.10.2. Market size, by application, 2014-2025 (USD Million)
      • 7.3.10.3. Market size, by end-users, 2014-2025 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2014-2025 (USD Million)
    • 7.4.2. Market size, by type, 2014-2025 (USD Million)
    • 7.4.3. Market size, by application, 2014-2025 (USD Million)
    • 7.4.4. Market size, by end-users, 2014-2025 (USD Million)
    • 7.4.5. Japan
      • 7.4.5.1. Market size, by type, 2014-2025 (USD Million)
      • 7.4.5.2. Market size, by application, 2014-2025 (USD Million)
      • 7.4.5.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.4.6. China
      • 7.4.6.1. Market size, by type, 2014-2025 (USD Million)
      • 7.4.6.2. Market size, by application, 2014-2025 (USD Million)
      • 7.4.6.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size, by type, 2014-2025 (USD Million)
      • 7.4.7.2. Market size, by application, 2014-2025 (USD Million)
      • 7.4.7.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Market size, by type, 2014-2025 (USD Million)
      • 7.4.8.2. Market size, by application, 2014-2025 (USD Million)
      • 7.4.8.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.4.9. Australia
      • 7.4.9.1. Market size, by type, 2014-2025 (USD Million)
      • 7.4.9.2. Market size, by application, 2014-2025 (USD Million)
      • 7.4.9.3. Market size, by end-users, 2014-2025 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2014-2025 (USD Million)
    • 7.5.2. Market size, by type, 2014-2025 (USD Million)
    • 7.5.3. Market size, by application, 2014-2025 (USD Million)
    • 7.5.4. Market size, by end-users, 2014-2025 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by type, 2014-2025 (USD Million)
      • 7.5.5.2. Market size, by application, 2014-2025 (USD Million)
      • 7.5.5.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by type, 2014-2025 (USD Million)
      • 7.5.6.2. Market size, by application, 2014-2025 (USD Million)
      • 7.5.6.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.5.7. Argentina
      • 7.5.7.1. Market size, by type, 2014-2025 (USD Million)
      • 7.5.7.2. Market size, by application, 2014-2025 (USD Million)
      • 7.5.7.3. Market size, by end-users, 2014-2025 (USD Million)
  • 7.6. MEA
    • 7.6.1. Market size, by country, 2014-2025 (USD Million)
    • 7.6.2. Market size, by type, 2014-2025 (USD Million)
    • 7.6.3. Market size, by application, 2014-2025 (USD Million)
    • 7.6.4. Market size, by end-users, 2014-2025 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. Market size, by type, 2014-2025 (USD Million)
      • 7.6.5.2. Market size, by application, 2014-2025 (USD Million)
      • 7.6.5.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.6.6. Saudi Arabia
      • 7.6.6.1. Market size, by type, 2014-2025 (USD Million)
      • 7.6.6.2. Market size, by application, 2014-2025 (USD Million)
      • 7.6.6.3. Market size, by end-users, 2014-2025 (USD Million)
    • 7.6.7. UAE
      • 7.6.7.1. Market size, by type, 2014-2025 (USD Million)
      • 7.6.7.2. Market size, by application, 2014-2025 (USD Million)
      • 7.6.7.3. Market size, by end-users, 2014-2025 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Astellas Pharma Inc
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. Capricor Therapeutics
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Cellectis
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. Cellular Dynamics
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Celyad
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. CESCA Therapeutic
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. DiscGenics
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. Gamida Cell
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Mesoblast Ltd
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Novadip Biosciences
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. OxStem
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
  • 8.12. ReNeuron Group plc
    • 8.12.1. Business overview
    • 8.12.2. Financial data
    • 8.12.3. Product landscape
    • 8.12.4. Strategic outlook
    • 8.12.5. SWOT analysis
  • 8.13. Takeda Pharmaceuticals
    • 8.13.1. Business overview
    • 8.13.2. Financial data
    • 8.13.3. Product landscape
    • 8.13.4. Strategic outlook
    • 8.13.5. SWOT analysis
Back to Top